<?xml version="1.0" encoding="UTF-8"?>
<p>Chikungunya disease is generally managed through supportive treatment and treatment strategies were reported in 283/2326 (12%) studies. Prescribed analgesics and anti-pyretics were reported in 87/283 (31%) studies, non-steroidal anti-inflammatory drugs (NSAIDs) in 80/283 (28%) studies and steroids in 70/283 (25%) studies; 
 <xref rid="pone.0207554.t001" ref-type="table">Table 1</xref>. Antibiotics were prescribed as treatment for chikungunya in 30/283 (11%) studies. There were 7/283 (2%) studies that described the use of antiviral drugs for chikungunya treatment and 29/283 (10%) studies described using an anti-malarial agent such as hydroxychloroquine to treat chikungunya symptoms. A randomized controlled trial examining the effectiveness of chloroquine to treat chikungunya concluded that there is no justification for its use during the acute stage of the illness [
 <xref rid="pone.0207554.ref260" ref-type="bibr">260</xref>]. Physical therapy or acupuncture were prescribed in 9/283 (3%) studies and 14/283 (5%) studies described the use of traditional medicine for treating chikungunya and its symptoms. The efficacy of plant-based drugs (19 studies), NSAIDs (17 studies), corticosteroids (19 studies), antivirals (17 studies) chloroquines (12 studies) and traditional medicines (8 studies) for treating acute and chronic symptoms of chikungunya was assessed in experimental studies.
</p>
